cephalosporin antibiotic

cephalosporin antibiotic

References in periodicals archive ?
Pernix or the Company), a specialty pharmaceutical company, today announced the sale of a non-core product, Cedax (ceftibuten capsules and ceftibuten for oral suspension), a third-generation cephalosporin antibiotic for the treatment of acute bacterial exacerbations of chronic bronchitis and middle ear infection, to SI Pharmaceuticals, LLC, for $2 million in gross cash proceeds.
Ceftobiprole is a cephalosporin antibiotic that is administered intravenously.
This increasing trend of antibiotic resistance against cephalosporin antibiotic give an indication that,due to close community interaction of backyard poultry with human population as well as the use of human left over food for feeding of backyard poultry is considered to be the important cause of this resistance pattern.
Resistance to the cephalosporin antibiotic cefixime, meanwhile, increased from 0.
Keflex (cephalexin capsules, USP) is a first-generation cephalosporin antibiotic shown to be active against strains of both gram-positive and gram-negative aerobes in vitro and in clinical infections.
Currently, CDC STD treatment guidelines recommend dual therapy with a cephalosporin antibiotic - Ceftriaxone is preferred - and either azithromycin or doxycycline to treat all uncomplicated gonococcal infections among adults and adolescents in the United States.
For example, the Food and Drug Administration approved the intravenous cephalosporin antibiotic ceftaroline in October 2010 for acute bacterial skin and soft tissue infections, including cases caused by MRSA.
The associate then re-prescribed the cephalosporin antibiotic that had led to the patient's C difficile illness in the first place.
If a patient has an immediate, life-threatening allergy to beta-lactam antibiotics, she should not receive a cephalosporin antibiotic for prophylaxis.
Ceftobiprole (BAL5788), Basilea's lead antibacterial product is the first cephalosporin antibiotic with both anti-MRSA and broad-spectrum activity in late-stage clinical trials.
The product is a broad-spectrum cephalosporin antibiotic.